H2BC5 Gene

Name H2B clustered histone 5
Description Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2B family. Two transcripts that encode the same protein have been identified for this gene, which is found in the large histone gene cluster on chromosome 6p22-p21.3. [provided by RefSeq, Aug 2015]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Replication‐dependent histone genes such as H2BC5 are critical components of the nucleosome and play an essential role in assembling chromatin and regulating gene expression. Post‐translational modifications of H2B proteins—including ubiquitylation, acetylation, and phosphorylation—help modulate RNA polymerase II engagement during transcription elongation, a process tightly controlled by kinases such as Cdk7."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In addition, experimental evidence shows that when regulatory factors like RGC‐32 are silenced, there is an increase in acetylation at specific lysine residues on histone H2B; such alterations in chromatin structure can accelerate cell‐cycle progression and potentially contribute to tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Consistent with this, several studies in cancer models have identified deregulation of histone H2B gene expression as a mechanism linked to chemotherapeutic resistance—for example, in breast cancer cells resistant to epirubicin, altered H2B expression appears to correlate with changes in apoptosis and proliferation dynamics."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Complementary transcriptomic analyses in other cancers have further highlighted modules of histone genes, including H2B variants, as prognostic markers, suggesting that mis‐regulation of these genes (and by extension, H2BC5) may impact disease progression and patient outcome."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, H2BC5, like other replication‐dependent H2B genes, contributes to the maintenance of chromatin structure and the regulation of gene transcription. Its post‐translational modification status is a key determinant of transcriptional fidelity and cell‐cycle progression, and dysregulation of H2B expression or modification may underlie drug resistance and cancer development. Such multifaceted roles position H2BC5 as both a potential biomarker and a therapeutic target in oncology and other disease settings.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Stéphane Larochelle, Ramon Amat, Kira Glover-Cutter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.2399"}], "href": "https://doi.org/10.1038/nsmb.2399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23064645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23064645"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic modifications induced by RGC-32 in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexmp.2009.10.010"}], "href": "https://doi.org/10.1016/j.yexmp.2009.10.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19883641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19883641"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Marsela Braunstein, Linda Liao, Nicola Lyttle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13058-016-0676-6"}], "href": "https://doi.org/10.1186/s13058-016-0676-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26852132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26852132"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jie Xiong, Shengyu Guo, Zhitong Bing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fgene.2018.00696"}], "href": "https://doi.org/10.3389/fgene.2018.00696"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30662454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30662454"}]}]}]}
NCBI Gene ID 3017
API
Download Associations
Predicted Functions View H2BC5's ARCHS4 Predicted Functions.
Co-expressed Genes View H2BC5's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View H2BC5's ARCHS4 Predicted Functions.

Functional Associations

H2BC5 has 3,606 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 29 datasets.

Click the + buttons to view associations for H2BC5 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of H2BC5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of H2BC5 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with H2BC5 gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of H2BC5 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing H2BC5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with H2BC5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with H2BC5 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with H2BC5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing H2BC5 protein from the curated GO Cellular Component Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of H2BC5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of H2BC5 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with H2BC5 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of H2BC5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of H2BC5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving H2BC5 protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of H2BC5 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
PFOCR Pathway Figure Associations 2024 pathways involving H2BC5 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving H2BC5 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of H2BC5 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of H2BC5 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of H2BC5 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of H2BC5 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of H2BC5 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of H2BC5 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of H2BC5 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of H2BC5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of H2BC5 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with H2BC5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving H2BC5 protein from the WikiPathways Pathways 2024 dataset.